Spark Therapeutics’ chief medical officer Kathy Reape is set to leave the biotech. Reape is one of the senior Spark staffers hitting the exit in the aftermath of Roche’s $4.3 billion takeover. Kathy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results